Discover KOL perspectives on best practices in VAD therapy. Register today to watch a comprehensive, 5-part webinar series hosted by Medtronic MCS, on
Optimizing Best Practices for LVAD Patient Management
Perspectives of Key Opinion Leaders in Mechanical Circulatory Support
Featuring webinars on the following topics with LIVE Q&A:
Recorded Video Coming Soon
Hear Dr. Andrew Sauer at University of Kansas Medical Center discuss which patient characteristics to consider when determining an HVAD candidate. Dr. Sauer will touch upon the patient, surgical, medical, and patient management considerations to discuss at your patient selection meeting.
Featuring:
Dr. Andrew Sauer
Associate Professor
Chief, Division of Advanced Heart Failure Therapies & Cardiac Transplantation
Department of Cardiovascular Medicine
University of Kansas Medical Center
Kansas City, Kansas
Hear Dr. Jay Pal at the University of Colorado discuss his approach to HVAD implantation. Dr. Pal will review how to determine the best surgical approach, and his tips and tricks for implanting HVAD via thoracotomy.
Featuring:
Dr. Jay Pal
Associate Professor of Cardiothoracic Surgery
Surgical Director, Mechanical Circulatory Support
University of Colorado
Aurora, Colorado
Recorded Video Coming Soon
Hear Dr. Erika Feller at the University of Maryland discuss best practices in post-operative care. Dr. Feller will speak to anticoagulation and antiplatelet management and share the University of Maryland Medical Center’s hematologic protocols.
Dr. Feller will also address pain management following a thoracotomy, wound care, and best practices in using Waveforms.
Featuring:
Dr. Erika Feller
Associate Professor of Medicine
Medical Director, Mechanical Circulatory Support and Transplant
Director of Cardiology Clinical Research
University of Maryland Medical Center
Baltimore, Maryland
Recorded Video Coming Soon
Hear Dr. Jonathan Rich at Northwestern discuss best practices for managing HVAD patients post-discharge. Dr. Rich will discuss blood pressure management, anticoagulation strategies, and using Waveforms to their full potential.
Featuring:
Dr. Jonathan Rich
Associate Professor of Medicine
Northwestern University, Feinberg School of Medicine
Medical Director, Mechanical Circulatory Support Program
Program Director, Advanced Heart Failure and Transplant Fellowship
Bluhm Cardiovascular Institute, Northwestern Memorial Hospital
Chicago, Illinois
Recorded Video Coming Soon
Hear Dr. Andrew Civitello at the Texas Heart Institute discuss key insights after 300 HVAD implants. Dr. Civitello will share best practices in patient selection, operative technique, post-operative protocols, and post-discharge patient management.
Featuring:
Dr. Andrew Civitello
Assistant Professor, Baylor College of Medicine
Medical Director, Heart Transplant Program
Co-Director, Advanced Heart Failure Center
Director, Advanced Heart Failure Fellowship
Baylor St. Luke's Medical Center / Texas Heart Institute
Brief Statement HeartWare™ HVAD™ System
Indications For Use:The HeartWare™ HVAD™ System is indicated for hemodynamic support in patients with advanced, refractory left ventricular heart failure; either as a Bridge to Cardiac Transplantation (BTT), myocardial recovery, or as Destination Therapy (DT) in patients for whom subsequent transplantation is not planned.
Contraindications: The HeartWare System is contraindicated in patients who cannot tolerate anticoagulation therapy. Warnings/Precautions: Proper usage and maintenance of the HVAD™ System is critical for the functioning of the device. Serious and life-threatening adverse events, including stroke, have been associated with use of this device. Blood pressure management may reduce the risk of stroke. Never disconnect from two power sources at the same time (batteries or power adapters) since this will stop the pump, which could lead to serious injury or death. At least one power source must be connected at all times. Always keep a spare controller and fully charged spare batteries available at all times in case of an emergency. Do not disconnect the driveline from the controller or the pump will stop. Avoid devices and conditions that may induce strong static discharges as this may cause the VAD to perform improperly or stop. Magnetic resonance imaging (MRI) could cause harm to the patient or could cause the pump to stop. The HVAD™ Pump may cause interference with automatic implantable cardioverter-defibrillators (AICDs), which may lead to inappropriate shocks, arrhythmia, and death. Chest compressions may pose a risk due to pump location and position of the outflow graft on the aorta — use clinical judgment. If chest compressions have been administered, confirm function and positioning of HVAD Pump post-CPR.
Potential Complications: Implantation of a VAD is an invasive procedure requiring general anesthesia and entry into the thoracic cavity. There are numerous known risks associated with this surgical procedure and the therapy including, but not limited to, death, stroke, neurological dysfunction, device malfunction, peripheral and devicerelated thromboembolic events, bleeding, right ventricular failure, infection, hemolysis, and sepsis. Refer to the “Instructions for Use” for detailed information regarding the implant procedure, indications, contraindications, warnings, precautions, and potential adverse events prior to using this device.
Caution: Federal law (USA) restricts these devices to sale by or on the order of a physician.
Indications, Safety and Warnings
Outside US Statement: HeartWare™ HVAD™ System
Indications for Use
The HVAD™ System is intended for use in patients at risk of death from refractory end-stage heart failure. The HVAD™ System is designed for in-hospital and out-of-hospital settings, including transportation via fixed wing aircraft or helicopter.
Contraindications
The HVAD™ System is contraindicated:
Warnings/Precautions
Proper usage and maintenance of the HVAD™ System is critical for the functioning of the device. Serious and life threatening adverse events, including stroke, have been associated with use of this device. Blood pressure management may reduce the risk of stroke. Never disconnect from two power sources at the same time (batteries or power adapters) since this will stop the pump, which could lead to serious injury or death. At least one power source must be connected at all times. Always keep a spare controller and fully charged spare batteries available at all times in case of an emergency. Do not disconnect the driveline from the controller or the pump will stop. Avoid devices and conditions that may induce strong static discharges as this may cause the VAD to perform improperly or stop. Magnetic resonance imaging (MRI) could cause harm to the patient or could cause the pump to stop. The HVAD™ Pump may cause interference with automatic implantable cardioverter-defibrillators (AICDs), which may lead to inappropriate shocks, arrhythmia and death. Chest compressions may pose a risk due to pump location and position of the outflow graft on the aorta -use clinical judgment. If chest compressions have been administered, confirm function and positioning of HVAD Pump post CPR. Potential Complications Implantation of a VAD is an invasive procedure requiring general anesthesia and entry into the thoracic cavity. There are numerous known risks associated with this surgical procedure and the therapy including, but not limited to, death, stroke, neurological dysfunction, device malfunction, peripheral and device-related thromboembolic events, bleeding, right ventricular failure, infection, hemolysis and sepsis. Refer to the “Instructions for Use” for detailed information regarding the implant procedure, indications, contraindications, warnings, precautions and potential adverse events prior to using this device.
